Literature DB >> 19877227

Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume.

Toshihiko Ikegami1, Yuichi Masuda, Yasunari Ohno, Atsushi Mita, Akira Kobayashi, Koichi Urata, Yuichi Nakazawa, Shirou Miwa, Yasuhiko Hashikura, Shinichi Miyagawa.   

Abstract

We have previously reported that a graft volume (GV) > 30% of the recipient's standard liver volume (SLV) can meet the recipient's metabolic demands. Here we report our experience with adult-to-adult living donor liver transplantation using left side grafts < 35% of the recipient's SLV. Of 143 adult living donor liver transplants, 13 auxiliary partial orthotopic liver transplants, 8 right side grafts, and 2 retransplantation cases were excluded. The resulting 120 cases were divided into 2 groups: group S consisted of 33 patients who received liver grafts < 35% of their SLV, and group L consisted of 87 patients who received liver grafts > or = 35% of their SLV. Patient characteristics, postoperative liver function, duration of hospital stay, and recipient survival rates were compared between the 2 groups. There were no significant differences between groups in recipient or donor background characteristics. The mean GV/SLV ratio of group S was 31.8%, whereas that of group L was 42.5%. There were no significant differences in the postoperative serum total bilirubin levels, prothrombin time international normalized ratio, daily ascites volume, or duration of postoperative hospital stay between the groups. The 1- and 5-year survival rates in group S were 80.7% and 64.2%, respectively, whereas those of group L were 90.8% and 84.9%, respectively, with no significant difference between groups. In conclusion, graft size was not considered to be the only cause of so-called small-for-size graft syndrome, and left side grafting appears to be the procedure of choice for adult-to-adult living donor liver transplantation because of the lower risk to donors in comparison with right lobe grafting.

Entities:  

Mesh:

Year:  2009        PMID: 19877227     DOI: 10.1002/lt.21716

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  Increasing donor body weight to prevent small-for-size syndrome in living donor liver transplantation.

Authors:  Chinsu Liu; Rheun-Chuan Lee; Che-Chuan Loong; Cheng-Yuan Hsia; Yi-Chen Yeh; See-Ying Chiou
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome.

Authors:  Jay A Graham; Benjamin Samstein; Jean C Emond
Journal:  Curr Transplant Rep       Date:  2014-03

3.  Efforts to expand the donor pool for liver transplantation.

Authors:  Rupesh Sutaria; David H Adams
Journal:  F1000 Med Rep       Date:  2010-06-16

4.  Quantitative study of liver hemodynamic changes in rats with small-for-size syndrome by the 4D-CT perfusion technique.

Authors:  Peiyi Xie; Li Quan; Sidong Xie; Binghui Chen; Kaikai Wei; Jie Ren; Xiaochun Meng
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

5.  Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation.

Authors:  Hany Shoreem; Emad Hamdy Gad; Hosam Soliman; Osama Hegazy; Sherif Saleh; Hazem Zakaria; Eslam Ayoub; Yasmin Kamel; Kalid Abouelella; Tarek Ibrahim; Ibrahim Marawan
Journal:  World J Hepatol       Date:  2017-07-28

6.  Outcomes of right-lobe and left-lobe living-donor liver transplantations using small-for-size grafts.

Authors:  Wong Hoi She; Kenneth Sh Chok; James Yy Fung; Albert Cy Chan; Chung Mau Lo
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

7.  Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe.

Authors:  Shinichi Matsudaira; Yoichi Ishizaki; Jiro Yoshimoto; Noriko Fujiwara; Seiji Kawasaki
Journal:  Transplant Direct       Date:  2017-02-16

8.  Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis.

Authors:  Ka Wing Ma; Kelly Hiu Ching Wong; Albert Chi Yan Chan; Tan To Cheung; Wing Chiu Dai; James Yan Yue Fung; Wong Hoi She; Chung Mau Lo; Kenneth Siu Ho Chok
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

9.  Pharmacological Evaluation of Hepatoprotective Activity of AHPL/AYTAB/0613 Tablet in Carbon Tetrachloride-, Ethanol-, and Paracetamol-Induced Hepatotoxicity Models in Wistar Albino Rats.

Authors:  Sanjay U Nipanikar; Sohan S Chitlange; Dheeraj Nagore
Journal:  Pharmacognosy Res       Date:  2017-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.